Q&A: Portland’s Gray Optics sees demand for precision components in COVID-19 tests

Founded in 2017, Gray Optics develops advanced imaging technologies and optical systems for biomedical, life sciences and industrial applications.

This year, the Portland company saw a surge in demand from manufacturers of COVID-19 “point-of-care” tests, which provide disease detection and diagnosis within minutes. Test manufacturers have come to Gray Optics asking for customized optical systems that are an integral part of the tests.

The challenge? Many rapid tests rely on fluorescence detection using a lens that must be precisely aligned, with regard to specifications such as field-of-view and depth-of-field, to a digital image sensor. The Gray Optics team designed those precision optical components for manufacturing at scale. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025